# Neurodegenerative Alzheimer's Disease and Amyotrophic Lateral Sclerosis (NADALS) Basket Trial

> **NCT05189106** · PHASE1,PHASE2 · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 17 (actual)

## Conditions studied

- Amyotrophic Lateral Sclerosis
- Alzheimer Disease
- Mild Cognitive Impairment

## Interventions

- **DRUG:** Baricitinib

## Key facts

- **NCT ID:** NCT05189106
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-12-05
- **Primary completion:** 2025-04-24
- **Final completion:** 2025-06-20
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2026-01-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05189106

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05189106, "Neurodegenerative Alzheimer's Disease and Amyotrophic Lateral Sclerosis (NADALS) Basket Trial". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05189106. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*